EMR vs ETN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

EMR

47.5
AI Score
VS
EMR Wins

ETN

42.4
AI Score

Investment Advisor Scores

EMR

48score
Recommendation
HOLD

ETN

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EMR ETN Winner
Forward P/E 21.8818 31.5457 EMR
PEG Ratio 1.8165 3.045 EMR
Revenue Growth 7.0% 21.4% ETN
Earnings Growth 23.0% -15.9% EMR
Tradestie Score 47.5/100 42.4/100 EMR
Profit Margin 13.8% 12.8% EMR
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

EMR 1M: +8.5% · 3M: +16.6% ETN 1M: +1.0% · 3M: +9.9%

Current Technical Phase

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 55

RSI (14): 55.0 · Price: $157.26

ETN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.4 · Price: $419.20

Fundamentals Snapshot

Metric EMR ETN
Market Cap
Forward P/E 21.7 26.1
Trailing P/E 34.5 43.3
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.5% 0.4%
Operating Margin 0.3% 0.2%
EPS 4.49 9.59
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.